Product Information
- (3b,6a,16b,20R,24S)-20,24-Epoxy-6,16,25-trihydroxy-9,19-cyclolanostan-3-yl12-O-b-D-glucopyranosyl-b-D-xylopyranoside
- (3beta,6alpha,9beta,16beta,20R,24S)-6,16,25-Trihydroxy-20,24-epoxy-9,19-cyclolanostan-3-yl 2-O-beta-D-glucopyranosyl-beta-D-xylopyranoside
- (3β,6α,16β,20R,24S)-20,24-Epoxy-6,16,25-trihydroxy-9,19-cyclolanostan-3-yl 2-O-β-<span class="text-smallcaps">D</smallcap>-glucopyranosyl-β-<smallcap>D</span>-xylopyranoside
- beta-D-xylopyranoside, (3beta,6alpha,9beta,16beta,20R,24S)-20,24-epoxy-6,16,25-trihydroxy-9,19-cyclolanostan-3-yl 2-O-beta-D-glucopyranosyl-
- β-<span class="text-smallcaps">D</smallcap>-Xylopyranoside, (3β,6α,16β,20R,24S)-20,24-epoxy-6,16,25-trihydroxy-9,19-cyclolanostan-3-yl 2-O-β-<smallcap>D</span>-glucopyranosyl-
Astragaloside III is a natural compound that inhibits the function of P-glycoprotein (P-gp) by binding to the drug transporter protein. It has been shown to inhibit the efflux of drugs from cells and to affect energy metabolism, which may be due to its ability to bind to a protein target. Astragaloside III also has anti-tumor response and biological properties, including inhibition of infectious diseases and surface methodology. Astragaloside III can be used in preparative hplc using glycoside derivatives, but when using matrix effect, 4-hydroxycinnamic acid is required. The lc-ms/ms method should be used for high-throughput screening.
Chemical properties
Technical inquiry about: 3D-OA09408 Astragaloside III
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
